Optimizing the treatment of hypertension in the primary care setting;Optimização de recursos no cuidado primário da hipertensão arterial

Arquivos Brasileiros de Cardiologia

Volumn 88, Issue 2, 2007, Pages

  Didier, Maria Teresa ^a,b   Guimarães, Armênio C ^a  

^a ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^b NONE   (Brazil)

Author keywords

Hypertension; Interdisciplinary team; Treatment

Indexed keywords

CAPTOPRIL; CLONIDINE; HYDROCHLOROTHIAZIDE; METHYLDOPA; NIFEDIPINE; PROPRANOLOL; ANTIHYPERTENSIVE AGENT; CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE PERSONNEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIMARY MEDICAL CARE; BLOOD; FOLLOW UP; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE DETERMINATION; CHOLESTEROL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT CARE TEAM; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 33947573355     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2007000200014     Document Type: Article

References (23)

1. 1993 Guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Bull World Health Organ. 1993; 71(5): 503-17.
2. McMahon S. Blood pressure, stroke and coronary heart disease- Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet.1990; 335: 765-74.
3. Collins R. Blood pressure, stroke and coronary heart disease. Part 2, short term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet. 1990; 335: 827-38.
4. The Seventh Report of the Joint National Committee on Prevention, detection, evaluation, and treatment of high blood pressure. The JNC 7 Report. JAMA. 2003; 289: 2560-72.
5. IV Diretrizes Brasileiras de Hipertensão Arterial: Epidemiologia. Rev Bras Hipertens. 2002; 9: 359-408.
6. Kim JS, Song WH, Shin C, Park CG, Seo HS, Shim WJ, et al. The prevalence and awareness of hypertension and the relationship between hypertension and snoring in the Korean population. Korean J Intern Med. 2001; 16: 62-8.
7. Prencipe M, Casini AR, Santini M, Ferretti C, Scaldaferri N, Culasso F. Prevalence, awareness, treatment and control of hypertension in the elderly: Results from population survey. J Hum Hypertens. 2000; 14: 825-30.
8. Jo I, Ahn Y, Lee J, Shin KR, Lee HK, Shin C. Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Asian study. J Hypertens. 2001; 19: 1523-32.
9. Stergiou GS, Thomopoulou GC, Skeva II, Mountokolakis TD. Prevalence, awareness, treatment, and control of hypertension in Greece: the Didima study. Am J Hypertens. 1999; 12: 959-65.
10. Kalavathy MC, Thankappan KR, Sarma PS, Vasan RS. Prevalence, awareness, treatment and control of hypertension in an elderly community-based sample in Kerala, India. Natl Med J India. 2000; 13: 9-15.
11. Stein AD, Stoyanovsky V, Mincheva V, Dimitrov E, Hodjeva D, Petrov A, et al. Prevalence, awareness, treatment and control of hypertension in a working Bulgarian population. Eur J Epidemiol. 2000; 16: 265-70.
12. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, et al. InterASIA Collaborative group. The International Collaborative Study of Cardiovascular Disease in ASIA. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension. 2002; 40: 920-7.
13. Tugay Aytekin N, Pala K, Irgil E, Akis N, Aytekin H. Distribution of blood pressures in Gemlik District, north-west Turkey. Health Soc Care Community. 2002; 10(5): 394-401.
14. Wolf, PA. Epidemiology of stroke. In: Barnett HJM, Mohr JP, Stein B, Yat su FM, editors. Stroke: pathophysiology, diagnosis and management. New York: Churchill Livingstone; 1992. p.3-27.
15. Lessa, I. Epidemiologia da hipertensão arterial sistêmica e da insuficiência cardíaca no Brasil. Rev Bras Hipertens. 2001; 8: 383-92.
16. Lewin AS, Skea ZC, Entwistle V, Zwarenstein M, Dick J. Interventions for providers to promote a patient-centered approach in clinical consultations. Cochrane Database Syst Rev. 2001;(4): CD003267
17. Ministério da Saúde. Funasa. CENEPI. Sistema de Informação de mortalidade (SIM) e IBGE. (on line). Citado em 2006 março 10. Disponível em: http://tabnet.datasus.gov.br/1999.
18. Ministério da Saúde - DATASUS. Anuário Estatístico de Saúde do Brasil 2001 (on line). Citado em 2005 fevereiro 20. Disponível em:. http://portal.saude.gov.br
19. Instituo Brasileiro de Geografia e Estatística. IBGE. Documentos estatísticos: saúde (on line). Citado em 2005 janeiro 21. Disponível em: www.ibge.gov.br
20. III Diretrizes Brasileiras sobre Dislipidemias e Diretriz de Prevenção da Aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol. 2001; 77(supl 3): 1-48.
21. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart Lung and Blood Institute Scientific Statement. Circulation. 2005; 112: 2735-52.
22. Sala A, Nemes A F, Eluf J Neto. Avaliação da efetividade do controle da hipertensão arterial em unidade básica de saúde. Rev Saúde Públ. 1996; 30: 161-7.
23. Ladeia AM, Guimarães AC. Assessment of risk factors in coronary patients being followed by cardiologists: control of risk factors in coronary patients. Prev Cardiol. 2003; 6(3): 122-7.